Amylyx Pharmaceuticals, Inc. (AMLX)

NASDAQ

$15.05

+$0.94 (6.66%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$13.92$15.25

Open $14.07

52 Week Range

$3.11$17.49

Previous Close $14.11

Market Cap1.17B

Volume1.28M

Avg Volume1.48M

P/E (TTM)-9.83

EPS (TTM)$-1.53

Dividend / YieldN/A

Dividend StreakN/A

About Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Company Info

SectorHealthcare

IndustryBiotechnology

CEOJoshua Cohen

Employees123

Websiteamylyx.com

Trading Information

Open

$14.07

Previous Close

$14.11

Day High

$15.25

Day Low

$13.92

52 Week High

$17.49

52 Week Low

$3.11